8-K
Current Report
Damora Therapeutics, Inc. Filed Acc 0001564590-22-004414
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading glto-8k_20220203.htm…